Trial intelligence / Profile preview

Biliary drainage with or without rifampicin in obstructive cholestasis

NL-OMON36732Not yet recruiting

Sponsor
Amsterdam University Medical Center
Start
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of rifampicin in Extrahepatic cholestasis (EHC), cholestatic pruritus and jaundice (2 arms), sponsored by Amsterdam University Medical Center. Planned start Feb 2012; status: not yet recruiting.

02

Drugs

rifampicin
03

Conditions

Extrahepatic cholestasis (EHC)cholestatic pruritusjaundice

Beyond the preview

Go deeper on NL-OMON36732.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36732.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call